Mirae Asset Global Investments Co. Ltd. Has $2.80 Million Stock Holdings in Waters Corporation $WAT

Key Points

• Mirae Asset Global Investments increased its stake in Waters Corporation by 12.6% during the second quarter, holding shares worth $2.8 million.
• Institutional investors and hedge funds have made significant adjustments to their holdings in Waters, with over 94% of the stock owned by these entities.
• Waters reported earnings of $2.95 per share for the last quarter, exceeding analysts' estimates, and set guidance for Q3 2025 earnings between 3.150-3.250 EPS.

Mirae Asset Global Investments Co. Ltd. raised its stake in shares of Waters Corporation (NYSE:WAT - Free Report) by 12.6% in the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 8,021 shares of the medical instruments supplier's stock after acquiring an additional 896 shares during the quarter. Mirae Asset Global Investments Co. Ltd.'s holdings in Waters were worth $2,800,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Lecap Asset Management Ltd. bought a new position in shares of Waters during the second quarter valued at $760,000. Robeco Institutional Asset Management B.V. boosted its holdings in shares of Waters by 16.3% in the 2nd quarter. Robeco Institutional Asset Management B.V. now owns 515,495 shares of the medical instruments supplier's stock worth $179,928,000 after acquiring an additional 72,174 shares in the last quarter. PFG Investments LLC boosted its holdings in shares of Waters by 4.4% in the 2nd quarter. PFG Investments LLC now owns 1,433 shares of the medical instruments supplier's stock worth $500,000 after acquiring an additional 60 shares in the last quarter. Truist Financial Corp boosted its holdings in shares of Waters by 8.7% in the 2nd quarter. Truist Financial Corp now owns 6,340 shares of the medical instruments supplier's stock worth $2,213,000 after acquiring an additional 509 shares in the last quarter. Finally, Janney Montgomery Scott LLC boosted its holdings in shares of Waters by 1.7% in the 2nd quarter. Janney Montgomery Scott LLC now owns 4,896 shares of the medical instruments supplier's stock worth $1,709,000 after acquiring an additional 83 shares in the last quarter. 94.01% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts have weighed in on WAT shares. UBS Group restated a "neutral" rating on shares of Waters in a research report on Tuesday, July 15th. Weiss Ratings restated a "hold (c)" rating on shares of Waters in a research report on Saturday, September 27th. Deutsche Bank Aktiengesellschaft set a $315.00 price objective on Waters and gave the stock a "hold" rating in a report on Tuesday, August 5th. Bank of America upped their price objective on Waters from $370.00 to $375.00 and gave the stock a "neutral" rating in a report on Thursday, June 26th. Finally, Wells Fargo & Company reduced their price objective on Waters from $330.00 to $315.00 and set an "equal weight" rating on the stock in a report on Tuesday, August 5th. One analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and nine have assigned a Hold rating to the company's stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average price target of $380.43.

Waters Stock Performance

NYSE WAT opened at $318.64 on Wednesday. The firm has a 50-day moving average of $297.74 and a 200-day moving average of $324.71. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.22 and a current ratio of 1.75. The stock has a market cap of $18.97 billion, a PE ratio of 28.73, a P/E/G ratio of 3.05 and a beta of 1.04. Waters Corporation has a 52-week low of $275.05 and a 52-week high of $423.56.

Waters (NYSE:WAT - Get Free Report) last posted its earnings results on Monday, August 4th. The medical instruments supplier reported $2.95 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.93 by $0.02. The company had revenue of $771.33 million during the quarter, compared to analysts' expectations of $745.96 million. Waters had a net margin of 21.71% and a return on equity of 38.60%. Waters's quarterly revenue was up 8.8% compared to the same quarter last year. During the same quarter last year, the company posted $2.63 EPS. Waters has set its Q3 2025 guidance at 3.150-3.250 EPS. FY 2025 guidance at 12.950-13.050 EPS. On average, sell-side analysts anticipate that Waters Corporation will post 12.86 EPS for the current year.

Waters Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.